Earningsreport

Q2/2023 6/30/2023 EPS -0.430 ZacksConsensus -0.430 ActVsEst 0.000 - In-Line

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations